Medline (MDLN) Gross Margin (2025 - 2026)
Medline (MDLN) reported Gross Margin of 25.04% for Q1 2026, down 241.0% year-over-year from 17.76% in Q1 2025, and down 8.79% on a QoQ basis from 27.45% in Q1 2025.
Medline (MDLN) has 2 years of Gross Margin data on file, last reported at 25.04% in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 146.28 Bn | 141.88 Bn | 1.83 Bn | 66.06% |
| 2 | Becton Dickinson | 41.14 Bn | 40.13 Bn | 2.15 Bn | 45.69% |
| 3 | Medline | 29.16 Bn | 35.00 Bn | 1.84 Bn | 25.04% |
| 4 | Resmed | 27.13 Bn | 25.47 Bn | 890.98 Mn | 62.25% |
| 5 | West Pharmaceutical Services | 22.71 Bn | 22.19 Bn | 296.40 Mn | 35.08% |
| 6 | Solventum | 13.26 Bn | 13.26 Bn | 1.10 Bn | 54.66% |
| 7 | Align Technology | 12.22 Bn | 11.16 Bn | 736.59 Mn | 70.82% |
| 8 | Cooper Companies | 11.79 Bn | 11.66 Bn | 695.20 Mn | 67.88% |
| 9 | Baxter International | 9.47 Bn | 7.42 Bn | 891.00 Mn | 32.99% |
| 10 | Aptargroup | 7.19 Bn | 6.99 Bn | 351.91 Mn | 35.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 25.04% |
| Mar 29, 2025 | 27.45% |